Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Dig Dis Sci. 2019 Aug 5;65(4):1144–1154. doi: 10.1007/s10620-019-05714-3

Table 1.

Patients’ characteristics.

Variable Controls RYGB-SWL RYGB-WR
N (serum) 11 14 21
Age, years 49.6±15.0 42.0±11.1 47.9±10.7
Gender (% Female) 81.8% 100% 95.5%
Race (%)
 White 81.8% 71.4% 45.5%
 African-American 9.1% 7.1% 9.1%
 Hispanic 9.1% 14.3% 40.9%
 Asian 0.0% 7.1% 0.0%
 Other 0.0% 0.0% 4.5%
Diabetes (n, %) 2, 18.2% 1, 7.1% 2, 9.1%
Initial BMI (kg/m2) 36.4±6.8 47.7±8.6 49.9±7.3
Nadir BMI (kg/m2) N/A 28.2±4.8 28.9±2.9
Current BMI (kg/m2) 36.4±6.8 29.4±4.6*# 37.9±5.7
Current weight (kg) 101.8±21.5 80.1±13.5*# 102.1±19.9
Years since surgery N/A 5.0±3.7* 8.9±3.0
Weight regain (kg) N/A 10.6±4.9
% EWL regained N/A 40±15.0%
#

denotes p<0.05 for control versus RYGB-SWL

*

denotes p<0.05 for RYGB-S versus RYGB-WR

EWL- excess weight loss

Results are mean ± standard deviation